Latest news articles

Added 8 months ago Drug news

FDA approves Imvexxy for treatment of moderate-to-severe dyspareunia.- TherapeuticsMD.

TherapeuticsMD announced that the FDA has approved Imvexxy (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia (vaginal pain associated...

Added 1 year ago Drug news

FDA issues Complete Response Letter for TX-004HR, an applicator-free vaginal estradiol softgel drug candidate for the treatment of moderate to severe dyspareunia.- Therapeutics MD Inc.

Therapeutics MD, Inc. announced that the Company received a letter from the FDA stating that, as part of the FDA’s...

Added 5 years ago Drug news

Cevira update on FDA discussions for Cervical Precancerous Lesions- PhotoCure

Photocure ASA, a specialty pharmaceutical company focused on photodynamic technologies in dermatology and cancer, announced an update on Cevira (hexaminolevulinate...

Search all news articles for Other female genital disorders
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

EADV 2018 Highlights

EADV 2018 Highlights

EADV Congress 2018: Bringing you the latest news and insights from 27th EADV Congress, 12-16 September 2018 Paris, France.

CDK 4/6 inhibitors in metastatic breast cancer

CDK 4/6 inhibitors in metastatic breast cancer

The CDK 4/6 Inhibitors in Metastatic Breast Cancer Learning Zone provides insights and information for metastatic breast cancer (mBC) and CDK 4/6 signalling. This includes the burden and pathophysiology of the disease, the role of CDK 4/6 in cell proliferation and an overview of the CDK 4/6 inhibitors that have been approved for the management of mBC.

Load more

Guidelines

Recurrent pregnancy loss

The overall aim of this guideline is to supply healthcare providers with the best available evidence for investigation and treatment of women with recurrent pregnancy loss.

Added 6 months ago

2014 UK National Guideline on the Management of Vulval Conditions

This guideline offers recommendation on the management of a range of vulval disorders who may present to Genitourinary Medicine clinics. Vulval disorders represent a disparate group of conditions with a variety of causes...

Added 5 years ago

Search all guidelines for Other female genital disorders
 

Journal articles

Efficacy of medroxyprogesterone acetate treatment and retreatment for atypical endometrial hyperplasia and endometrial cancer.

Aim: Medroxyprogesterone acetate (MPA) is used to preserve fertility in patients with Grade 1 endometrial cancer without myometrial invasion (G1EA) and those with atypical endometrial hyperplasia (AEH).

Added 1 year ago

Hysteroscopic local anaesthetic intrauterine cornual ‘focal local’ block before endometrial ablation with direct cervical block in an outpatient setting: a feasibility study

Objective:To evaluate the safety, feasibility and efficacy of a hysteroscopic local anaesthetic intrauterine cornual block (ICOB) on women's perception of...

Added 5 years ago

Functional endometrial polyps in infertile asymptomatic patients: a possible evolution of vascular changes secondary to endometritis

Objective:Functional polyps and chronic endometritis are among the most common abnormalities seen in the endometrium of patients with implantation failures...

Added 5 years ago

Search all journal articles for Other female genital disorders
 

CME

Vulvovaginal atrophy

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
1
Registration required
1
Subscription fee
0

Postcoital bleeding - red flag symptoms

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
0
Registration required
1
Subscription fee
0

Pelvic organ prolapse

Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
1
Registration required
1
Subscription fee
90
Search all CME for Other female genital disorders